Skip to content

Assembly Biosciences ASMB Customer receivables and Other

Customer receivables and Other at other companies

USCB Financial Holdings, Inc. logo
USCB Financial Holdings, Inc.USCB
$203.75K
Morgan Stanley logo
Morgan StanleyMS
$2.52B+0.4%
McEwen Mining logo
McEwen MiningMUX
$385K+6.6%
Raymond James Financial logo
Raymond James FinancialRJF
$1.81B-3.5%
Chicago Atlantic Real Estate Finance logo
Chicago Atlantic Real Estate FinanceREFI
$2.56M+388%
Arbor Realty Trust logo
Arbor Realty TrustABR
$35.25M+267%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's customer receivables and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's customer receivables and other?
Assembly Biosciences (ASMB) reported customer receivables and other of $2.29M in Q1 2026.
How has Assembly Biosciences's customer receivables and other changed year-over-year?
Assembly Biosciences's customer receivables and other increased by 104.0% year-over-year, from $1.12M to $2.29M.
What is the long-term trend for Assembly Biosciences's customer receivables and other?
Over 4 years (2021 to 2025), Assembly Biosciences's customer receivables and other has grown at a 111.1% compound annual growth rate (CAGR), from $302K to $6M.